• Education
  •  Download App
  • Country
    singapore
    hong kong
    malaysia
    indonesia
    thailand
    philippines
    vietnam
    india

    australia
    korea
    new zealand
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
  • Home
  • Find Drugs
  • Find Drug Company
  • Diseases
  • Medical News & Updates
The CIMS logo.
Home
Find Drugs
Find Drug Company
Diseases
Medical News & Updates

Other Services
 Education
  Download App
Country
singapore
hong kong
malaysia
indonesia
thailand
philippines
vietnam
australia
korea
new zealand
Account
The CIMS logo.
  1. Diseases
  2. Acute Coronary Syndromes w/out Persistent ST-Segment Elevation
  3. ...
    • Diseases
    • Acute Coronary Syndromes w/out Persistent ST-Segment Elevation
  4. Follow Up

Acute Coronary Syndromes w/out Persistent ST-Segment Elevation Follow Up

Last updated: 02 April 2025
Reviewed by
Test Board 123 editedPAGINATION TESTMIMS Cardiology Honorary Editorial Advisory Board
Disease SummaryDisease AlgorithmDisease BackgroundInitial AssessmentDiagnosticsDifferential DiagnosisManagementFollow UpReferences
Follow Up
  • Disease Summary
  • Disease Algorithm
  • Disease Background
  • Initial Assessment
  • Diagnostics
  • Differential Diagnosis
  • Management
  • References
Follow up
Content:
Monitoring

Content on this page:

Monitoring

Content on this page:

Monitoring

Monitoring

Follow-up is focused on the patient's individual profile and level of risk. Low- and intermediate-risk medically treated patients and revascularized patients may have a follow-up appointment in 2 to 6 weeks, while high- and very high-risk patients may follow up in 1 to 2 weeks. This provides an opportunity to check and manage adverse reactions from treatment as well as treatment adherence, optimize control of risk factors and achievement of treatment goals, monitor lifestyle modifications, reinforce the importance of continuing secondary preventive measures, and educate about the disease. Outpatient evaluation of low-risk NSTE-ACS patients may include echocardiography for assessment of LV function, stress echocardiography (treadmill or pharmacological stress), treadmill stress test, cardiac MRI (stress MRI for ischemia and perfusion MRI for viability), and nuclear perfusion study. Patients with significant demonstrable ischemia should be referred for coronary angiography for potential revascularization.

The CIMS logo.
  • Drugs
  • Find Drugs
  • Find Drug Company
  • CIMS Abbreviation Index
  • Diseases
  • Search Disease Information
  • Editorial Advisory Board
  • Medical News & Updates
  • Latest News & Updates
  • More Services
  • Education
  • Subscribe
  • About
  • MIMS Corporate
  • Terms of Use
  • Privacy Policy
  • Feedback
Connect with CIMS
A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.A social media brand icon.
TUV Nord ISO 9001 certification logo
CIMS Specialty uat/incremental2.2_2011.1
Copyright © 2025 CIMS Pte Ltd. All rights reserved. UAT
CIMS Logo

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?

Sign up for Free to continue reading

Already a member?
Something went wrong.